<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03376100</url>
  </required_header>
  <id_info>
    <org_study_id>030021</org_study_id>
    <nct_id>NCT03376100</nct_id>
  </id_info>
  <brief_title>Distal Nerve Blocks for Closed Reduction of Distal Forearm Fractures</brief_title>
  <official_title>Ultrasound Guided Radial and Median Nerve Blocks Versus Haematoma Block for Closed Reduction of Distal Forearm Fractures; a Randomised Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regionshospitalet Viborg, Skive</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Randers Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Herning Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial comparing the standard haematoma block used for reduction of&#xD;
      distal forearm fractures in the Emergency Department with ultrasound guided nerveblocks. The&#xD;
      investigators hypothesize that ultrasound guided blocking of the radial and median nerves&#xD;
      will improve fracture reduction satisfaction for the true Colles' fractures and improve&#xD;
      analgesia for reduction of all distal forearm fracture types compared to the standard&#xD;
      haematoma block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicenter randomized controlled trial comparing the standard hematoma block as the local&#xD;
      anaesthetic procedure for reduction of distal forearm fracture with ultrasound guided radial&#xD;
      and median nerve blocks.&#xD;
&#xD;
      Among all dislocated fractures of the distal forearm only the true Colles' fracture can&#xD;
      potentially be treated adequately with a closed reduction and a cast, while the other&#xD;
      fracture types are unstable by definition and require surgical stabilization. Most dislocated&#xD;
      forearm fractures, however, require a primary reduction and this procedure requires the&#xD;
      patient to be relieved of pain and the muscle traction on the fracture to be minimal. The&#xD;
      conventional local anaesthetic procedure used in Denmark is the hematoma block where the&#xD;
      local anaesthetic agent is injected directly in the fracture. This is done using either a&#xD;
      blind technique or with the aid of X-ray to visualize the fracture line. The radial and&#xD;
      median nerves supply periosteal innervation for the radius and the ulna as well as muscular&#xD;
      innervation for the majority of muscles in the forearm and wrist. Blocking these nerves at&#xD;
      the level of the cubital fossa should relieve pain and minimize muscular traction when&#xD;
      performing closed reductions on distal forearm fractures.&#xD;
&#xD;
      The investigators hypothesize that ultrasound guided blocking of the radial and median nerves&#xD;
      will improve fracture reduction satisfaction for the true Colles' fractures and improve&#xD;
      analgesia for reduction of all fracture types compared to the standard haematoma block.&#xD;
&#xD;
      Patients eligible for screening for inclusion are identified in the Emergency Department (ED)&#xD;
      at all recruitment sites upon primary contact. When an X-ray has revealed the relevant&#xD;
      fracture, the ED-staff will call the available anaesthesiologist or anaesthesiologist trainee&#xD;
      who will perform the inclusion process and randomisation. Participants will be randomized in&#xD;
      either the intervention or the control group using the online randomization tool Research&#xD;
      Electronic Data Capture (REDCap, Aarhus University, Denmark). In both groups, the reduction&#xD;
      process will begin 10 minutes after the block has been performed. The technique for the&#xD;
      actual reduction may vary amongst physicians. To best reflect the clinical practices and to&#xD;
      avoid the risk of an insufficient reduction due to the physician being forced to comply to a&#xD;
      technique unfamiliar to him, no further standardisation will be made in this regard.&#xD;
      Following casting of the fracture a control X-ray will be performed and subsequently&#xD;
      evaluated independently by two skilled orthopaedic surgeons to establish if the reduction was&#xD;
      satisfactory. In case of disputes a third orthopaedic surgeon will evaluate the X-ray and&#xD;
      make a final ruling. The fracture will be deemed satisfactory using a binary outcome measure&#xD;
      (yes/no) if all the following requirements set by the National Clinical Guideline for&#xD;
      Treatment of Distal Radius Fractures are met.&#xD;
&#xD;
      Binary data, including primary endpoint will be analysed using chi squared test. For normally&#xD;
      distributed measurements the differences between groups will be compared using Student´s&#xD;
      t-test. Variables considered not to be normally distributed will be analysed by&#xD;
      Mann-Whitney´s U-test. Two-tailed P-values &lt; 0.05 will be considered statistically&#xD;
      significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction satisfaction</measure>
    <time_frame>Within 8 hours from admission</time_frame>
    <description>Based on objective X-ray measures according to the Danish National Guideline for Treatment of Distal Forearm Fractures. The primary outcome applies for the true Colles' fractures only.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain, during reduction</measure>
    <time_frame>Within 8 hours from admission</time_frame>
    <description>Pain score using an 11-step numeric rating scale (0-1-2-3-4-5-6-7-8-9-10, with 0 being no pain and 10 being worst pain imanigable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain, when local anaesthetic is injected</measure>
    <time_frame>Within 8 hours from admission</time_frame>
    <description>Pain score using an 11-step numeric rating scale (0-1-2-3-4-5-6-7-8-9-10, with 0 being no pain and 10 being worst pain imanigable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent on reduction</measure>
    <time_frame>Within 8 hours from admission</time_frame>
    <description>Time stamp start; when reduction begins. Time stamp end; when casting is complete</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary fracture dislocation</measure>
    <time_frame>Records obtained 2 months after primary treatment</time_frame>
    <description>Measured by the need for surgical stabilization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Fracture Closed of Lower End of Forearm, Unspecified</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with distal forearm fractures randomized to Hematoma Block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with distal forearm fractures randomized to Ultrasound guided nerve block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound guided nerve blocks</intervention_name>
    <description>Ultrasound guided nerve blocks of the radial and median nerves</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hematoma Block</intervention_name>
    <description>Conventional local anesthetic method using hematoma block</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  Presence of a closed distal forearm fracture in need of a closed reduction&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Legally competent&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
&#xD;
          -  Allergy or intolerance towards local anaesthetics&#xD;
&#xD;
          -  Infection or burns at either injection site&#xD;
&#xD;
          -  Multi trauma (defined as other fractures or significant injuries)&#xD;
&#xD;
          -  Known pregnancy&#xD;
&#xD;
          -  Participation in other studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anette B Christensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Anesthesiology-Intensive Care Medicine, Reional Hospital Viborg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anette B Christensen, MD</last_name>
    <phone>+45 24 66 63 32</phone>
    <email>anettebrojensen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoffer G Sølling, MD, PhD</last_name>
    <phone>+ 45 78 44 52 12</phone>
    <email>chrsoell@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. Anesthesia and Intensive Care, Viborg Regional Hospital</name>
      <address>
        <city>Viborg</city>
        <zip>DK-8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anette Bro, MD</last_name>
      <phone>+45 24 66 63 32</phone>
      <email>anettebrojensen@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Christoffer Sølling, MD, PhD</last_name>
      <phone>+45 78445212</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>December 6, 2017</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Christoffer Grant Sølling</investigator_full_name>
    <investigator_title>Consultant, Head of Research, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/00/NCT03376100/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 2, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/00/NCT03376100/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

